Recent headlines about “superbug” transmission by endoscopes highlight the importance of high-quality decision making when information about adverse consequences surfaces after medical devices are marketed. Existing practice (ISO 14971) emphasizes the use of the Risk Matrix, which lacks foundation in decision science and may lead to arbitrary decision making.
|
|
Scooped by
Decision Intelligence
onto Decision Intelligence News February 8, 2016 11:48 AM
|
Your new post is loading...

The SDP webinars are excellent. Highly recommended.